There are 2789 resources available
354P - Extended dosing (12 cycles) vs. conventional dosing (6 cycles) of adjuvant temozolomide in adults with newly diagnosed high grade gliomas: A randomized, single-blind, two-arm, parallel-group controlled trial
Presenter: Seyed Alireza Javadinia
Session: ePoster Display
355P - Butterfly glioblastoma: Treatment strategies and clinical outcome
Presenter: Line Bjorland
Session: ePoster Display
Resources:
Abstract
433P - Durvalumab and tremelimumab in combination with FOLFOX in patients with previously untreated RAS-mutated metastatic colorectal cancer: First results of efficacy at one year for phase II MEDITREME trial
Presenter: Jean-David Fumet
Session: ePoster Display
358P - Anlotinib plus temozolomide for recurrent glioma: A single-center, retrospective study of 30 cases
Presenter: Yuandong Cao
Session: ePoster Display
359P - Regorafenib in recurrent glioblastoma patients: A large real-life experience
Presenter: Giuseppe Lombardi
Session: ePoster Display
276P - Dalpiciclib, a novel CDK4/6 inhibitor, combined with pyrotinib for HER2+ advanced breast cancer: Interim results of a phase II trial
Presenter: Min Yan
Session: ePoster Display
277P - Phase II randomized study of trimebutine maleate and probiotics for abemaciclib-induced diarrhea in patients with HR-positive and HER2-negative advanced breast cancer (MERMAID) WJOG11318B
Presenter: Hiroko Masuda
Session: ePoster Display
278P - Plasmid encoding p62/SQSTM1 administered in combination with CMF chemotherapy improves outcomes in metastatic triple-negative breast cancer patients
Presenter: Sergei Krasny
Session: ePoster Display